Patent ID: 11897877
Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. A compound according to claim 1, wherein R6 is a 5 membered heteroaryl comprising 1, 2, or 3 nitrogen atoms;
and wherein R6 is optionally further substituted by one or more substituent groups independently selected from halo, cyano, hydroxy, NR22R23, (1-4C)alkoxy, (1-4C)alkyl, (1-5C)alkylsulphonyl, 3 to 6 membered heterocyclyl, 3 to 6 membered heterocyclyl-(1-2C)alkyl, 5 or 6 membered heteroaryl, 5 or 6 membered heteroaryl-(1-2C)alkyl, CONR22R23, and SO2NR22R23; wherein R22 and R23 are each independently hydrogen or (1-4C)alkyl.